Indeed, advanced EGFR-mutant lung adenocarcinoma patients with higher PD-L1 expression had worse PFS [40, 41], OS, and a lower frequency of secondary T790M mutation [41]. The gene discussed is EGFR; the disease is lung adenocarcinoma.